MARKET

SNN

SNN

Smith & Nephew
NYSE
24.23
+0.72
+3.06%
Closed 16:01 10/04 EDT
OPEN
24.13
PREV CLOSE
23.51
HIGH
24.38
LOW
24.07
VOLUME
1.42M
TURNOVER
--
52 WEEK HIGH
37.28
52 WEEK LOW
21.50
MARKET CAP
10.55B
P/E (TTM)
21.43
1D
5D
1M
3M
1Y
5Y
Smith & Nephew goes ex-dividend tomorrow
Smith &amp; Nephew (NYSE:SNN) had declared <a href="https://www.sm...
Seekingalpha · 6d ago
Smith+Nephew first to market with revision knee indication on robotics platform
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee replacement utilizing its CORI◊ Surgical System. Dr. Thorsten Seyler of Duke University performed the first cases on August 17, 2022, ...
PR Newswire · 09/26 12:00
Burberry Finance Chief Joins GSK As First Woman CFO
Benzinga · 09/26 11:50
GSK Names Burberry Executive Julie Brown New Finance Chief
GSK Names Burberry Executive Julie Brown New Finance Chief
MT Newswires · 09/26 04:52
Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it is expanding the reach of its medical education curriculum through a suite of advanced simulation technologies. Healthcare professionals can now conveniently access ...
PR Newswire · 09/21 12:00
Smith & Nephew's Implant Shows 86% Reduction In Re-Tear Rates After Shoulder Surgery
Benzinga · 09/14 16:24
Another day, another profits warning – but here's why you should stick by Smith & Nephew
Oh dear. Just when it seemed like Smith & Nephew was making progress, the FTSE 100 company has dished out another profits warning.
The Telegraph · 08/09 05:00
Is There An Opportunity With Smith & Nephew plc's (LON:SN.) 36% Undervaluation?
In this article we are going to estimate the intrinsic value of Smith & Nephew plc ( LON:SN. ) by taking the forecast...
Simply Wall St. · 08/05 05:27
More
About SNN
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. The Company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Webull offers kinds of Smith & Nephew plc (ADR) stock information, including NYSE:SNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNN stock methods without spending real money on the virtual paper trading platform.